Advertisements
Gefitinib
| Price: | US$ 930 / Kilogram |
|---|---|
| Minimum Order: | 1kg |
| Payment Terms: | Western Union, Moneygram,Bitcoin,Bank Wire |
| Port of Export: | HongKong |
Product Details
| Model No.: | Brand Name: | Zhuhai Wumei |
|---|
| Certification: | ISO9001 |
|---|---|
| Specification: | Package: 1kg/bag |
Packaging & Delivery
| Packaging: | we use discreet and safe package, we also provide customized package |
|---|---|
| Delivery/Lead Time: | 7 to 12 days |
| Production Capacity: | 100~200kg/month |
Product Description
Product name: Gefitinib
Synonyms: N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine Gefitinib;Gefitinib, >=99%;N-(3-Chlor-4-fluorophenyl)-7-[methoxy-6-[(3-morpholin-4-yl)propoxyl]-quinazolin-4-yl]amine;GEFITINIB RELATED COMPOUND;Gefitinib(TINIBS);6-(Benzyloxy)-7-methoxyquinazolin-4(3H)-one;Gefinitib;(3-chloro-4-fluoro-phenyl)-[7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-yl]amine
CAS:184475-35-2
MF:C22H24ClFN4O3
MW:446.9
Product Categories:Inhibitors;Anticancer;Active Pharmaceutical Ingredients;Gefitinib;Molecular Targeted Antineoplastic;Intermediates & Fine Chemicals;Pharmaceuticals;Pharmaceutical intermediate;APIs;IRESSA;Anti-cancer&immunity;API.
Indications and Uses Gifitinib is an antineoplastic target therapy drug with relatively high specificity that was developed by the British pharmaceutical company AstraZeneca; it is the first molecular targeted drug to be used in non-small cell lung cancer treatment.
|
SUPPLIER PROFILE
|
|||
|---|---|---|---|
| Company: | Zhuhai Wumei Technology Co., Ltd. | ||
| City/State | Zhuhai, Guangdong | Country: |
China 
|
| Business Type: | Export - Manufacturer / Trading Company | Established: | 2009 |
| Member Since: | 2018 | Contact Person | Jack Song |
SUPPLIER PROFILE
City/State/Country -
Zhuhai, Guangdong
China
Business Type -
Export - Manufacturer / Trading Company
Established -
2009
Member Since -
2018
Contact Person -
Jack Song